These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27126903)

  • 1. Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy.
    Yao C; Liu J; Wu X; Tai Z; Gao Y; Zhu Q; Li J; Zhang L; Hu C; Gu F; Gao J; Gao S
    J Control Release; 2016 Jun; 232():203-14. PubMed ID: 27126903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric Hybrid Nanomicelles for Cancer Theranostics: An Efficient and Precise Anticancer Strategy for the Codelivery of Doxorubicin/miR-34a and Magnetic Resonance Imaging.
    Xie X; Chen Y; Chen Z; Feng Y; Wang J; Li T; Li S; Qin X; Wu C; Zheng C; Zhu J; You F; Liu Y; Yang H
    ACS Appl Mater Interfaces; 2019 Nov; 11(47):43865-43878. PubMed ID: 31684723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma.
    Qian X; Long L; Shi Z; Liu C; Qiu M; Sheng J; Pu P; Yuan X; Ren Y; Kang C
    Biomaterials; 2014 Feb; 35(7):2322-35. PubMed ID: 24332459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of reduced polypeptide micelle for co-delivery of doxorubicin and TRAIL against drug-resistance in breast cancer.
    Hu C; Gu F; Tai Z; Yao C; Gong C; Xia Q; Gao Y; Gao S
    Oncotarget; 2016 Sep; 7(38):61832-61844. PubMed ID: 27557520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer.
    Wen D; Peng Y; Lin F; Singh RK; Mahato RI
    Cancer Res; 2017 Jun; 77(12):3244-3254. PubMed ID: 28428276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed Nanosized Polymeric Micelles as Promoter of Doxorubicin and miRNA-34a Co-Delivery Triggered by Dual Stimuli in Tumor Tissue.
    Salzano G; Costa DF; Sarisozen C; Luther E; Mattheolabakis G; Dhargalkar PP; Torchilin VP
    Small; 2016 Sep; 12(35):4837-4848. PubMed ID: 27432595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
    Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
    Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor.
    Zhao Y; Zhou Y; Wang D; Gao Y; Li J; Ma S; Zhao L; Zhang C; Liu Y; Li X
    Acta Biomater; 2015 Apr; 17():182-92. PubMed ID: 25612838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment.
    Liang X; Wang Y; Shi H; Dong M; Han H; Li Q
    Int J Nanomedicine; 2021; 16():2569-2584. PubMed ID: 33833512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo.
    Zhu Y; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
    J Control Release; 2016 Jul; 233():29-38. PubMed ID: 27178807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer.
    Rokhlin OW; Scheinker VS; Taghiyev AF; Bumcrot D; Glover RA; Cohen MB
    Cancer Biol Ther; 2008 Aug; 7(8):1288-96. PubMed ID: 18497571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of doxorubicin and (131)I by thermosensitive micellar-hydrogel for enhanced in situ synergetic chemoradiotherapy.
    Huang P; Zhang Y; Wang W; Zhou J; Sun Y; Liu J; Kong D; Liu J; Dong A
    J Control Release; 2015 Dec; 220(Pt A):456-464. PubMed ID: 26562684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facile construction of dual-bioresponsive biodegradable micelles with superior extracellular stability and activated intracellular drug release.
    Chen W; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
    J Control Release; 2015 Jul; 210():125-33. PubMed ID: 25987525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic drug-based self-assembled polyelectrolyte complex micelles: Physicochemical, pharmacokinetic, and anticancer activity analysis.
    Ramasamy T; Poudel BK; Ruttala H; Choi JY; Hieu TD; Umadevi K; Youn YS; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2016 Oct; 146():152-60. PubMed ID: 27318960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic gene and drug tumor therapy using a chimeric peptide.
    Han K; Chen S; Chen WH; Lei Q; Liu Y; Zhuo RX; Zhang XZ
    Biomaterials; 2013 Jun; 34(19):4680-9. PubMed ID: 23537665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioreducible poly(2-ethyl-2-oxazoline)-PLA-PEI-SS triblock copolymer micelles for co-delivery of DNA minicircles and Doxorubicin.
    Gaspar VM; Baril P; Costa EC; de Melo-Diogo D; Foucher F; Queiroz JA; Sousa F; Pichon C; Correia IJ
    J Control Release; 2015 Sep; 213():175-191. PubMed ID: 26184050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of the autophagy inhibitor si-Beclin1 and the doxorubicin nano-delivery system for advanced prostate cancer treatment.
    Hu C; Gu F; Gong C; Xia Q; Gao Y; Gao S
    J Biomater Appl; 2022 Feb; 36(7):1317-1331. PubMed ID: 34856824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile dynamic one-step modular assembly based on boronic acid-diol for construction of a micellar drug delivery system.
    Zhao Z; Zhang Y; Tian C; Yin T; Zhang C
    Biomater Sci; 2018 Sep; 6(10):2605-2618. PubMed ID: 30124690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.